Abstract:Purpose of review: Gastroparesis is a chronic disorder characterized by a constellation of foregut symptoms, including postprandial nausea, vomiting, distension, epigastric pain, and regurgitation in the absence of gastric outlet obstruction. Despite considerable research over the past decades, there remains to be only nominal understanding of disease classification, diagnostic criteria, pathogenesis, and preferred therapy. Recent findings: We critically reassess current approaches for disease identification and stratification, theories of causation, and treatment for gastroparesis. Gastric scintigraphy, long considered a diagnostic standard, has been re-evaluated in light of evidence showing low sensitivity, whereas newer testing modalities are incompletely validated. Present concepts of pathogenesis do not provide a unified model linking biological impairments with clinical manifestations, whereas available pharmacological and anatomical treatments lack explicit selection criteria or evidence for sustained effectiveness. We propose a disease model that embodies the re-programming of distributed neuro-immune interactions in the gastric wall by inflammatory perturbants. These interactions, combined with effects on the foregut hormonal milieu and brain-gut axis, are postulated to generate the syndromic attributes characteristically linked with gastroparesis. Research linking models of immunopathogenesis with diagnostic and therapeutic paradigms will lead to reclassifications of gastroparesis that guide future trials and technological developments. Key points: • The term gastroparesis embodies a heterogenous array of symptoms and clinical findings based on a complex assimilation of afferent and efferent mechanisms, gastrointestinal locations, and pathologies. • There currently exists no single test or group of tests with sufficient capacity to be termed a definitional standard for gastroparesis. • Present research regarding pathogenesis suggests the importance of immune regulation of intrinsic oscillatory activity involving myenteric nerves, interstitial cells of Cajal, and smooth muscle cells. • Prokinetic pharmaceuticals remain the mainstay of management, although novel treatments are being studied that are directed to alternative muscle/nerve receptors, electromodulation of the brain-gut axis, and anatomical (endoscopic, surgical) interventions.

Current and emerging pharmacotherapy for the treatment of gastroparesis

Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists

Diabetic Gastroparesis: Principles and Current Trends in Management

[An update on gastroparesis in 2024]

Gastric peroral endoscopic myotomy for gastroparesis: A systematic review of efficacy and safety.

Reconsideration of the Gastroparetic Syndrome

Diabetic Gastroparesis: Perspectives From a Patient and Health Care Providers

The goals for successful development of treatment in gastroparesis

ACG Clinical Guideline: Gastroparesis

Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment

Diabetic Gastroparesis and its Emerging Therapeutic Options: A Narrative Review of the Literature

Common Pathophysiological Mechanisms and Treatment of Diabetic Gastroparesis

Pathogenesis and management of diabetic gastroparesis: An updated clinically oriented review

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis

Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment

S2341 New Endoscopic Approaches Versus Conventional Surgical Interventions in the Management of Refractory Gastroparesis: A Network Meta-Analysis

Efficacy and Safety of Complementary and Alternative Medicine Therapy for Gastroparesis: A Protocol for Systematic Review and Meta-Analysis

A Gluco-Mindful Approach To Diabetic Gastroparesis

Disorders of gastric motility

Gastric Electrical Stimulation as a New Treatment Modality for Refractory Nausea and Vomiting with Normal Gastric Emptying

Initial experience and outcomes of per oral pyloromyotomy for the treatment of refractory gastroparesis